Mayo Clinic Laboratory and pathology research roundup: May 16

By Samantha Rossi • May 16, 2023

Share this:

The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.

Featured Abstract

Development and validation of an acute respiratory distress syndrome prediction model in Coronavirus Disease 2019: Updated lung injury prediction score.

To develop and validate an updated lung injury prediction score for coronavirus disease 2019 (COVID-19) (c-LIPS) tailored for predicting acute respiratory distress syndrome (ARDS) in COVID-19.

Read more.

Published to PubMed This Week

• The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.
  British journal of haematology
• Hereditary gelsolin amyloidosis: A rare cause of cranial, peripheral and autonomic neuropathies linked to D187N and Y447H substitutions.
  Amyloid
• Detection of endometrial cancer using tampon-based collection and methylated DNA markers.
  Gynecologic Oncology
• Perianal Treponema pallidum.
  Mayo Clinic Proceedings
• Heart failure with preserved ejection fraction: JACC scientific statement.
  Journal of the American College of Cardiology
• Immune checkpoint inhibitor associated central nervous system autoimmunity.
  European Journal of Neurology
• Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): A global, randomised, placebo-controlled, phase 3 study.
  The Lancet. Oncology
• Clinical manifestations, treatment and outcomes of patients infected with Mycobacterium haemophilum with a focus on immune reconstitution inflammatory syndrome: A retrospective multi-site study.
  Infectious disease (London, England)
• Relationship among three common hematological premalignant conditions.
  Leukemia
  

Samantha Rossi

Samantha Rossi is a Digital Marketing Manager at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.